TCI GENE Statistics
Total Valuation
TCI GENE has a market cap or net worth of TWD 932.66 million. The enterprise value is 129.40 million.
| Market Cap | 932.66M |
| Enterprise Value | 129.40M |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Sep 5, 2025 |
Share Statistics
TCI GENE has 26.46 million shares outstanding. The number of shares has increased by 0.48% in one year.
| Current Share Class | 26.46M |
| Shares Outstanding | 26.46M |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 10.95% |
| Owned by Institutions (%) | 1.71% |
| Float | 4.03M |
Valuation Ratios
The trailing PE ratio is 23.19.
| PE Ratio | 23.19 |
| Forward PE | n/a |
| PS Ratio | 3.41 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | 6.18 |
| P/OCF Ratio | 6.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.22, with an EV/FCF ratio of 0.86.
| EV / Earnings | 3.19 |
| EV / Sales | 0.47 |
| EV / EBITDA | 5.22 |
| EV / EBIT | 10.10 |
| EV / FCF | 0.86 |
Financial Position
The company has a current ratio of 9.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 9.27 |
| Quick Ratio | 8.94 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.04 |
| Interest Coverage | 14.97 |
Financial Efficiency
Return on equity (ROE) is 4.09% and return on invested capital (ROIC) is 23.99%.
| Return on Equity (ROE) | 4.09% |
| Return on Assets (ROA) | 1.24% |
| Return on Invested Capital (ROIC) | 23.99% |
| Return on Capital Employed (ROCE) | 2.29% |
| Weighted Average Cost of Capital (WACC) | 5.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.26 |
| Inventory Turnover | 3.71 |
Taxes
| Income Tax | -108,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.32% in the last 52 weeks. The beta is 0.17, so TCI GENE's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -37.32% |
| 50-Day Moving Average | 36.16 |
| 200-Day Moving Average | 39.79 |
| Relative Strength Index (RSI) | 44.74 |
| Average Volume (20 Days) | 6,304 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TCI GENE had revenue of TWD 273.61 million and earned 40.57 million in profits. Earnings per share was 1.52.
| Revenue | 273.61M |
| Gross Profit | 152.59M |
| Operating Income | 20.93M |
| Pretax Income | 38.97M |
| Net Income | 40.57M |
| EBITDA | 32.91M |
| EBIT | 20.93M |
| Earnings Per Share (EPS) | 1.52 |
Balance Sheet
The company has 831.73 million in cash and 6.32 million in debt, with a net cash position of 825.40 million or 31.20 per share.
| Cash & Cash Equivalents | 831.73M |
| Total Debt | 6.32M |
| Net Cash | 825.40M |
| Net Cash Per Share | 31.20 |
| Equity (Book Value) | 912.65M |
| Book Value Per Share | 33.52 |
| Working Capital | 815.65M |
Cash Flow
In the last 12 months, operating cash flow was 151.33 million and capital expenditures -417,000, giving a free cash flow of 150.91 million.
| Operating Cash Flow | 151.33M |
| Capital Expenditures | -417,000 |
| Depreciation & Amortization | 11.98M |
| Net Borrowing | -6.91M |
| Free Cash Flow | 150.91M |
| FCF Per Share | 5.70 |
Margins
Gross margin is 55.77%, with operating and profit margins of 7.65% and 14.83%.
| Gross Margin | 55.77% |
| Operating Margin | 7.65% |
| Pretax Margin | 14.24% |
| Profit Margin | 14.83% |
| EBITDA Margin | 12.03% |
| EBIT Margin | 7.65% |
| FCF Margin | 55.16% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 5.56%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 5.56% |
| Dividend Growth (YoY) | -33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 130.45% |
| Buyback Yield | -0.48% |
| Shareholder Yield | 5.08% |
| Earnings Yield | 4.35% |
| FCF Yield | 16.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |